News Center

This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced,…

Ipsen is committed to bringing innovative medicines to the rare disease community where a significant…

As part of our commitment to accelerating transformative research and development, we’re excited to announce…

We are deeply saddened by the tragic earthquake across Turkey and Syria and the worsening…

Hear what Ipsen CEO David Loew has to say about our strong full year and…

Ipsen leaders will attend the J.P. Morgan Healthcare Conference from January 9-12, 2023, in San…

‘Invisible’ diseases like primary biliary cholangitis (PBC) can be difficult to recognise, diagnose and to…

You can never truly understand what it’s like to live with an ultra-rare condition unless…

In December 2021, Ipsen received ISO 37001 certification for its anti-corruption management systems by Eurocompliance,…

"Our growth platforms have delivered strong sales performance, reflecting improving commercial execution and the strength…

Ipsen announces that it becomes a founding sponsor of the second Biolabs innovation brain hub…

By Hamzah Baig, Senior Global Medical Affairs Director for Neuroscience at Ipsen   Continuing medical…